Eric ChengPrincipal

Eric Cheng is the Principal of LYZZ Capital. He has more than 10 years of industry experience in the medical field and has participated in the investment work of a number of well-known domestic and foreign companies. Bofore joining LYZZ Capital, he worked at Jianxin Capital, Medtronic (Shanghai) Medical Devices Co., Ltd. Eric invested in a number of biomedical companies, including of Chipscreen, Alpha Biopharma, Donglei Brain Hospital, Newmed Medical, Neurelis, Qpex, HLI, Wugen, among others.


Eric received a medical degree from Fudan University, a master's degree in biotechnology and medicine from the Chinese Academy of Sciences, and an MBA degree from Boston College.